Cases & Deals

Share

Merz GmbH acquires Pharma Investment Holding

May 2008

Client(s) Merz GmbH & Co. KGaA

Jones Day advised Merz GmbH & Co. KGaA in its acquisition of Pharma Investment Holding S.A. which holds a 100% share in BioteCon Therapeutics GmbH.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.